Erin Darakjian - 01 Nov 2022 Form 3 Insider Report for P3 Health Partners Inc. (PIII)

Role
Interim CFO, Senior VP & CAO
Signature
/s/ Jessica Puathasnanon, as attorney-in-fact
Issuer symbol
PIII
Transactions as of
01 Nov 2022
Net transactions value
$0
Form type
3
Filing time
09 Nov 2022, 15:05:59 UTC
Next filing
30 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PIII Stock Option (Right to Buy) 01 Nov 2022 Class A Common Stock 50,000 $4.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable with respect to 20% of the shares on each of August 15, 2023, August 15, 2024, August 15, 2025, August 15, 2026 and August 15, 2027, subject to the Reporting Person's continued service through the applicable vesting date. The option was granted on October 31, 2022.

Remarks:

Exhibit 24 - Power of Attorney